Nov 23 (Reuters) - Johnson & Johnson's JNJ.N McNeil unit has begun a voluntary recall of Children's Benadryl allergy tablets, in cherry and grape flavors, citing insufficiencies in the development of the manufacturing process.
The recent recall was the latest to hit J&J, which has been plagued by massive recalls of numerous consumer products, such as Children’s Tylenol and Motrin, keeping those medicines off pharmacy shelves for months.
J&J’s McNeil Consumer Healthcare also said it started a voluntary recall of Junior Strength Motrin Caplets, 24 count, that were distributed in the United States.
The company has recalled about 4 million packages of Children’s Benadryl allergy tablets and about 800,000 bottles of junior-strength Motrin caplets, a Bloomberg report said.
In its Benadryl website, the drug giant said it was a wholesale and retail level recall, and that no action was required by consumers or healthcare providers.
“This recall is not being undertaken on the basis of adverse events,” the company added.
J&J could not immediately be reached for comment by Reuters.
Shares of the company closed at $63.62 Monday on the New York Stock Exchange. (Reporting by Thyagaraju Adinarayan and S. John Tilak in Bangalore; Editing by Jon Loades-Carter)
Our Standards: The Thomson Reuters Trust Principles.